How Analysts Feel About IGAMBIT INCORPORATED (OTCMKTS:IGMB) After Decrease in Sellers?

February 13, 2018 - By Vivian Park

The stock of IGAMBIT INCORPORATED (OTCMKTS:IGMB) registered a decrease of 86.21% in short interest. IGMB’s total short interest was 1,200 shares in February as published by FINRA. Its down 86.21% from 8,700 shares, reported previously. With 4,400 shares average volume, it will take short sellers 0 days to cover their IGMB’s short positions.

The stock decreased 2.78% or $0.0011 during the last trading session, reaching $0.0384. About 7,100 shares traded. iGambit Inc. (OTCMKTS:IGMB) has 0.00% since February 13, 2017 and is . It has underperformed by 16.70% the S&P500.

iGambit Inc., focuses on the end to end software-as-a-service solutions that manages, reports, and analyzes critical data. The company has market cap of $4.78 million. It also offers fully-hosted cloud services for healthcare providers to conduct the medicare annual wellness visit program to their medicare patients with a 5-10 years personalized preventive plan, and physician reports. It currently has negative earnings. In addition, the AWV program allows a physician to identify those patients that have 2+ chronic conditions, and require additional screening and management.

More notable recent iGambit Inc. (OTCMKTS:IGMB) news were published by: which released: “iGambit Inc.’s HealthDatix signs Tele-Health Wearables contract with Axcel …” on November 02, 2017, also with their article: “iGambit Announces Acquisition of ArcMail, a Leading Provider of Email …” published on November 10, 2015, published: “iGambit making two high-tech acquisitions” on February 16, 2017. More interesting news about iGambit Inc. (OTCMKTS:IGMB) were released by: and their article: “IGAMBIT Announces Acquisition of HUBCENTRIX INC. A Leading Provider of …” published on February 15, 2017 as well as‘s news article titled: “HealthDatix signs contract with Endeavor Plus” with publication date: October 09, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: